Respiratory syncytial virus causes increased bronchial epithelial permeability

Chest
Muna M KilaniVeena B Antony

Abstract

Respiratory syncytial virus (RSV)-induced diseases are mediated through active cytokines released during infection. We hypothesized that RSV infection causes bronchial epithelial monolayer permeability in vitro via induction of vascular endothelial growth factor (VEGF). Human bronchial epithelial cells were infected with RSV. In some cultures, VEGF antibody was included to block VEGF response; in other cultures, palivizumab was added to block RSV infection. Permeability was assessed in real-time using electric cell-substrate impedance sensing. VEGF release was assessed using enzyme-linked immunosorbent assay. Gap formation was assessed using live cell imaging. RSV-infected cells demonstrated a decrease in the resistance of the monolayer indicating an increase in permeability; this increase was blocked with VEGF-specific antibody, and palivizumab. Intercellular gap formation developed in RSV-infected epithelial monolayers. RSV increases permeability of the bronchial airway epithelial monolayer via VEGF induction.

References

Oct 1, 1995·American Journal of Respiratory Cell and Molecular Biology·W M ManiscalcoM H Campbell
Aug 1, 1995·The Journal of Infectious Diseases·A R FalseyR F Betts
Jul 1, 1996·The Journal of Allergy and Clinical Immunology·R DodgeB Burrows
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B MeisterR Möhle
Oct 27, 1999·JAMA : the Journal of the American Medical Association·D K ShayL J Anderson
Feb 8, 2000·Biological Chemistry·P ScheideggerR Jaussi
Nov 4, 2000·American Journal of Respiratory Cell and Molecular Biology·C G LeeJ A Elias
Feb 28, 2002·American Journal of Respiratory Cell and Molecular Biology·Nathalie CarayolPascal Chanez
Apr 3, 2003·The Pediatric Infectious Disease Journal·Peter J OpenshawFiona J Culley

❮ Previous
Next ❯

Citations

Jul 18, 2012·Antioxidants & Redox Signaling·Roberto P GarofaloAntonella Casola
Jan 25, 2008·Journal of Virology·Julia Eckardt-MichelGert Zimmer
Jun 15, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Divyendu SinghFarhad Imani
Sep 2, 2011·BMC Infectious Diseases·Raquel AlmansaJesus F Bermejo-Martin
Jan 1, 2014·American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics·Thyagaseely PremarajSundaralingam Premaraj
Nov 3, 2012·Enfermedades infecciosas y microbiología clínica·Raquel AlmansaRaúl Ortiz de Lejarazu Leonardo
Jul 25, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H ZhaoW Tong
Sep 29, 2011·Alcoholism, Clinical and Experimental Research·Samantha M SimetJoseph H Sisson
Mar 24, 2009·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Maria PinoRaul Ortiz de Lejarazu
Dec 3, 2016·The Journal of General Virology·Carla BellinghausenFrank R M Stassen
May 2, 2018·Annals of the American Thoracic Society·Nicolas BougasIsabelle Momas
Jan 22, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Desmond M MurphyJames L Lordan
Nov 20, 2019·Journal of Clinical Medicine·Konstantinos LoverdosNikoletta Rovina
Sep 4, 2019·Biosensors & Bioelectronics·Ava HedayatipourNicole McFarlane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2022 Meta ULC. All rights reserved